Global Viral Clearance Service Market - Snapshot

The global viral clearance service market was valued at US$ 261.9 Mn in 2017 and is anticipated to reach US$ 902.1 Mn by 2026, expanding at a CAGR of 14.9% from 2018 to 2026. Increase in demand for detection of virus removal/inactivation in products during their early stages of development, rise in R&D expenditure, growing preference for outsourcing of viral clearance service to contract research organizations, rise in consumer awareness about safety associated with the use of health care and vaccines, and increase in concern of viral effects of blood-derived products are some factors boosting the demand for viral clearance service. Moreover, emergence of technologies, such as nanofilteration and chromatography services, and choice of choosing the method depends on type of product, process, and regulatory. The user would need to determine the level of virus clearance required (as per logarithmic reduction) before marketing approval of new molecules. Companies have started focusing on efficacy and quality with high investments in R&D owing to stringent restructuring of regulations by both U.S. FDA and the European Medicines Agency that have put in place requirements for viral safety in relation to biologics. This has ultimately helped boost the viral clearance service market.

The viral clearance service market is witnessing robust expansion owing to increasing complexity of clinical trials, greater number of regulatory hurdles, and high investment required for infrastructure that results in greater clinical trials cost. Consequently, rising number of pharmaceutical companies are partnering with viral clearance service providers having the requisite infrastructure and expertise to manage costs and deadlines. Moreover, increasing focus on specialty drugs is likely to fuel the market, as specialty drugs require scientific expertise and highly tailored clinical trials that significantly increase costs.

viral-clearance-service-market.jpg

The viral clearance service market has been segmented based on application, method, end-user, and region. In terms of applications, the recombinant proteins segment is estimated to account for a prominent share of the market. Rising prevalence of diseases, such as cardiovascular, diabetes, and oncological, robust pipeline of pharmaceutical and biopharmaceutical products, increasing expenditure on research and development, rising emphasis on innovative treatment therapies for existing as well upcoming diseases, increasing demand for outsourcing analytical testing, and optimal service provided by the viral clearance service provider companies are major factors driving the global viral clearance service market.

In terms of method, the global viral clearance services has been classified into viral removal and viral inactivation method. The viral removal segment leads the market and accounts for a major share, as it is a robust and effective method of removal of different types of viruses. It is also expensive, safe, and brings about a high degree of purity of sample. The viral inactivation segment has been further sub-segmented into chemical, radiation, and others such as pasteurization and dry and moist heat treatment.

In terms of end-user, the global viral clearance service market has been categorized into biopharmaceuticals, contract research organizations, academic research institutes and other end-users. The biopharmaceuticals segment held a major market share in 2017. This can be attributed to the rise in R&D expenditure of these industries, increased outsourcing of clinical studies to contract research organizations that enables them to manage R&D costs and focus on their core competencies, and increase in pressure from regulatory agencies for viral removal/inactivation process in order to prove product safety to obtain market approval.

In terms of region, the global viral clearance service market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global viral clearance services market due to the presence of a large number of viral clearance removal/inactivation service providers, high health care spending, and stringent regulations governing safety assessment of biologics and vaccines. Europe follows North America in terms of share of the market, which can be ascribed to the amendment of regulation made by governments in Europe in order to assess the safety of biological substances. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period owing to the emergence of CROs offering viral clearance services, as per regulatory requirements at a lower cost than that in other developed regions.

Prominent players operating in the global viral clearance service market include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA (BioReliance), WuXi AppTec, Clean Cells, and Vironova Biosafety. Key players are expanding their product portfolio through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical and biotechnology companies and by providing better services at a lower cost.

Growing Need for Safe Drug Development to Bring Tremendous Growth Opportunities for the Viral Clearance Service Market

The viral clearance service market is expected to gain good growth opportunities across the assessment period of 2018-2026 on the back of the rising demand for virus detection in specialty drugs and biological products. The growing demand for virus inactivation among a large number of drugs and biological products may bring extensive growth opportunities for the viral clearance service market.

  • Viral clearance services are utilized for the removal of bacteria or viruses that are present on drugs, production equipment, or biological products. The services include the testing of end-products and ensure consistent and safe development of biological products. All these aspects bode well for the growth of the viral clearance service market.
  • The rising numbers of diseases and disorders around the world have prompted many pharmaceutical companies to launch novel drugs and medicines that treat the conditions or disorders at a faster pace. The growing drug production levels may bring extensive growth prospects for the viral clearance service market.
  • Research and development activities have a large role in the growth of the viral clearance service market. The players in the viral clearance service market invest in these activities for exploring insights that help in adding more features to the services. These features eventually help in boosting the growth prospects of the viral clearance service market.
  • Strategic collaborations are also playing a crucial role in the growth of the viral clearance service market. The players indulge in mergers, acquisitions, joint ventures, and partnerships for strengthening their foothold in the viral clearance service market, ultimately increasing the growth rate of the viral clearance service market.
  • The COVID-19 pandemic has a minimal effect on the growth of the viral clearance service market. The services and production related to the healthcare sector were exempted from the strict lockdown restrictions, which served as a relief for the players in the viral clearance service market.

Global Viral Clearance Service Market: Overview

This report on the global viral clearance service market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on application, method, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global viral clearance service market.

Global Viral Clearance Service Market: Key Segments

Based on application, the global viral clearance service market has been segmented into recombinant proteins, tissue and blood derived products, vaccines, and others. In terms of method, the market has been classified into viral removal and viral inactivation. The viral inactivation segment has been further sub-segmented into chemical, radiation, and others. In terms of end-user, the market has been segregated into biopharmaceuticals, contract research organizations, academic research institutes, and other end-users. The global viral clearance service market has been analyzed based on increasing regulatory scrutiny, technology trend, expenditure on emerging technologies, and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year.

Global Viral Clearance Service Market: Regional Outlook

In terms of region, the global viral clearance service market has been categorized into five major regions, and key countries in these regions are: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, viz. 2018-2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.

Companies Mentioned in Report

The report profiles the major players operating in the global viral clearance service market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA (BioReliance), WuXi AppTec, Clean Cells, and Vironova Biosafety.

The global viral clearance service market has been segmented as follows:

by Application

  • Recombinant Proteins
  • Tissue and Blood Derived Products
  • Vaccines
  • Others

by Method

  • Viral Removal
  • Viral Inactivation
    • Chemical
    • Radiation
    • Other

by End-user

  • Biopharmaceuticals
  • Contract Research Organizations
  • Academic Research Institutes
  • Other End-users

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology
     2.1. Assumptions
     2.2. Research Methodology

3. Executive Summary : Global Viral Clearance Service
     3.1.Global Viral Clearance Service Market Value (US$ Mn) and Distribution, by Geography, 2017 and 2026
     3.2. Global Viral Clearance Service Market Snapshot, 2017
     3.3. Global Viral Clearance Service Market: Opportunity Map

4. Market Overview
     4.1. Introduction
            4.1.1. Application Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
                     4.3.1.1. Increased outsourcing of viral clearance testing studies
                     4.3.1.2. Rise in R&D expenditure
                     4.3.1.3. Rise in focus on early clearance of virus in biologics
                     4.3.1.4. Increased burden of regulatory requirements
                     4.3.1.5. Technological advancements
                     4.3.1.6. Growing economies of the world
            4.3.2. Restraints
                     4.3.2.1. Reduction of preclinical outsourcing budget by some of the large pharma companies
                     4.3.2.2. High cost and complexity involved in the development and approval of biologics and biosimilars
            4.3.3. Opportunities
     4.4. Global Viral Clearance Service Market Analysis and Forecast, 2016–2026
            4.4.1. Global Viral Clearance Service Market Value (US$ Mn) Forecast
     4.5. Porter’s Five Force Analysis

5. Market Outlook
     5.1. Regulatory Scenario by Region/globally
     5.2. Key Mergers & Acquisitions
     5.3. Technological Advancements
     5.4. Key Market Trends
     5.5. Competitive Landscape Analysis (based on strategic developments of players)
     5.6. Future Prospects Assessment

6. Global Viral Clearance Service Market Analysis and Forecast, by Application
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Viral Clearance Service Market Value Forecast, by Application, 2016–2026
            6.3.1. Recombinant Proteins
            6.3.2. Tissue and Blood Derived Products
            6.3.3. Vaccines
            6.3.4. Others
     6.4. Global Viral Clearance Service Market Attractiveness, by Application

7. Global Viral Clearance Service Analysis and Forecast, by Method
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Viral Clearance Service Market Value Forecast, by Method, 2016–2026
            7.3.1. Viral Removal
            7.3.2. Viral Inactivation
                     7.3.2.1. Chemical
                     7.3.2.2. Radiation
                     7.3.2.3. Other
     7.4. Global Viral Clearance Service Market Attractiveness, by Method

8. Global Viral Clearance Service Analysis and Forecast, by End-user
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Global Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
            8.3.1. Biopharmaceuticals
            8.3.2. Contract Research Organizations
            8.3.3. Academic Research Institutes
            8.3.4. Other End-users
     8.4. Global Viral Clearance Service Market Attractiveness by End-user

9. Global Viral Clearance Service Analysis and Forecast, by Region
     9.1. Key Findings
     9.2. Global Viral Clearance Service Market Value Forecast, by Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East & Africa
     9.3. Global Viral Clearance Service Market Attractiveness, by Region

10. North America Viral Clearance Service Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. North America Viral Clearance Service Market Value Forecast, by Application, 2016–2026
            10.2.1. Recombinant Proteins
            10.2.2. Tissue and Blood Derived Products
            10.2.3. Vaccines
            10.2.4. Others
     10.3. North America Viral Clearance Service Market Value Forecast, by Method, 2016–2026
            10.3.1. Viral Removal
            10.3.2. Viral Inactivation
                     10.3.2.1. Chemical
                     10.3.2.2. Radiation
                     10.3.2.3. Other
     10.4. North America Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
            10.4.1. Biopharmaceuticals
            10.4.2. Contract Research Organizations
            10.4.3. Academic Research Institutes
            10.4.4. Other End-users
     10.5. North America Viral Clearance Service Market Value Forecast, by Country, 2016–2026
            10.5.1. U.S.
            10.5.2. Canada
     10.6. North America Viral Clearance Service Market Attractiveness Analysis
            10.6.1. By Application
            10.6.2. By Method
            10.6.3. By End-user
            10.6.4. By Country

11. Europe Viral Clearance Service Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2. Europe Viral Clearance Service Market Value Forecast, by Application, 2016–2026
            11.2.1. Recombinant Proteins
            11.2.2. Tissue and Blood Derived Products
            11.2.3. Vaccines
            11.2.4. Others
     11.3. Europe Viral Clearance Service Market Value Forecast, by Method, 2016–2026
            11.3.1. Viral Removal
            11.3.2. Viral Inactivation
                     11.3.2.1. Chemical
                     11.3.2.2. Radiation
                     11.3.2.3. Other
     11.4. Europe Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
            11.4.1. Biopharmaceuticals
            11.4.2. Contract Research Organizations
            11.4.3. Academic Research Institutes
            11.4.4. Other End-users
     11.5. Europe Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
            11.5.1. Germany
            11.5.2. U.K.
            11.5.3. France
            11.5.4. Spain
            11.5.5. Italy
            11.5.6. Rest of Europe
     11.6. Europe Viral Clearance Service Market Attractiveness Analysis
            11.6.1. By Application
            11.6.2. By Method
            11.6.3. By End-user
            11.6.4. By Country/Sub-region

12. Asia Pacific Viral Clearance Service Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2. Asia Pacific Viral Clearance Service Market Value Forecast, by Application, 2016–2026
            12.2.1. Recombinant Proteins
            12.2.2. Tissue and Blood Derived Products
            12.2.3. Vaccines
            12.2.4. Others
     12.3. Asia Pacific Viral Clearance Service Market Value Forecast, by Method, 2016–2026
            12.3.1. Viral Removal
            12.3.2. Viral Inactivation
                     12.3.2.1. Chemical
                     12.3.2.2. Radiation
                     12.3.2.3. Other
     12.4. Asia Pacific Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
            12.4.1. Biopharmaceuticals
            12.4.2. Contract Research Organizations
            12.4.3. Academic Research Institutes
            12.4.4. Other End-users
     12.5. Asia Pacific Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
     12.6. Asia Pacific Viral Clearance Service Market Attractiveness Analysis
            12.6.1. By Application
            12.6.2. By Method
            12.6.3. By End-user
            12.6.4. By Country/Sub-region

13. Latin America Viral Clearance Service Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
     13.2. Latin America Viral Clearance Service Market Value Forecast, by Application, 2016–2026
            13.2.1. Recombinant Proteins
            13.2.2. Tissue and Blood Derived Products
            13.2.3. Vaccines
            13.2.4. Others
     13.3. Latin America Viral Clearance Service Market Value Forecast, by Method, 2016–2026
            13.3.1. Viral Removal
            13.3.2. Viral Inactivation
                     13.3.2.1. Chemical
                     13.3.2.2. Radiation
                     13.3.2.3. Other
     13.4. Latin America Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
            13.4.1. Biopharmaceuticals
            13.4.2. Contract Research Organizations
            13.4.3. Academic Research Institutes
            13.4.4. Other End-users
     13.5. Latin America Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
     13.6. Latin America Viral Clearance Service Market Attractiveness Analysis
            13.6.1. By Application
            13.6.2. By Method
            13.6.3. By End-user
            13.6.4. By Country/Sub-region

14. Middle East & Africa Viral Clearance Service Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
     14.2. Middle East & Africa Viral Clearance Service Market Value Forecast, by Application, 2016–2026
            14.2.1. Recombinant Proteins
            14.2.2. Tissue and Blood Derived Products
            14.2.3. Vaccines
            14.2.4. Others
     14.3. Middle East & Africa Viral Clearance Service Market Value Forecast, by Method, 2016–2026
            14.3.1. Viral Removal
            14.3.2. Viral Inactivation
                     14.3.2.1. Chemical
                     14.3.2.2. Radiation
                     14.3.2.3. Other
     14.4. Middle East & Africa Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
            14.4.1. Biopharmaceuticals
            14.4.2. Contract Research Organizations
            14.4.3. Academic Research Institutes
            14.4.4. Other End-users
     14.5. Middle East & Africa Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
            14.5.1. GCC Countries
            14.5.2. South Africa
            14.5.3. Rest of Middle East & Africa
     14.6. Middle East & Africa Viral Clearance Service Market Attractiveness Analysis
            14.6.1. By Application
            14.6.2. By Method
            14.6.3. By End-user
            14.6.4. By Country/Sub-region

15. Competition Landscape
     15.1. Global Viral Clearance Service Market Player – Competition Matrix (by Tier and Size of companies)
     15.2. Global Viral Clearance Service Market Share Analysis, by Company (2017)
     15.3. Competitive Business Strategies
     15.4. Company Profiles
            15.4.1. Texcell
                     15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.1.2. Company Financials
                     15.4.1.3. Growth Strategies
                     15.4.1.4. Recent Events
                     15.4.1.5. SWOT Analysis
            15.4.2. Eurofins Scientific SE
                     15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.2.2. Company Financials
                     15.4.2.3. Growth Strategies
                     15.4.2.4. Recent Events
                     15.4.2.5. SWOT Analysis
            15.4.3. Charles River Laboratories International, Inc.
                     15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.3.2. Company Financials
                     15.4.3.3. Growth Strategies
                     15.4.3.4. Recent Events
                     15.4.3.5. SWOT Analysis
            15.4.4. Merck KGaA (BioReliance)
                     15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.4.2. Company Financials
                     15.4.4.3. Growth Strategies
                     15.4.4.4. Recent Events
                     15.4.4.5. SWOT Analysis
            15.4.5. WuXi AppTec
                     15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.5.2. Company Financials
                     15.4.5.3. Growth Strategies
                     15.4.5.4. Recent Events
                     15.4.5.5. SWOT Analysis
            15.4.6. Clean Cells
                     15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.6.2. Company Financials
                     15.4.6.3. Growth Strategies
                     15.4.6.4. Recent Events
                     15.4.6.5. SWOT Analysis
            15.4.7. Vironova Biosafety
                     15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.7.2. Company Financials
                     15.4.7.3. Growth Strategies
                     15.4.7.4. Recent Events
                     15.4.7.5. SWOT Analysis

List of Tables

Table 01: Global Viral Clearance Service Market Value (US$ Mn) Forecast, 2016–2026
Table 02: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 04: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 08: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 09: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 10: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 13: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 14: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 15: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 19: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 20: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 23: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 24: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 25: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 26: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 28: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 29: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 30: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 31: Competition Matrix

List of Figures

Figure 01: Global Viral Clearance Service Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 03: Global Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 04: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Recombinant Proteins, 2016–2026
Figure 05: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Tissue and Blood Derived Products, 2016–2026
Figure 06: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
Figure 07: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 08: Global Viral Clearance Service Market Attractiveness Analysis, by Application, 2018–2026
Figure 09: Global Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 10: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Viral Removal , 2016–2026
Figure 11: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Viral Inactivation, 2016–2026
Figure 12: Global Viral Clearance Service Market Attractiveness Analysis, by Method, 2018–2026
Figure 13: Global Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 14: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Biopharmaceuticals, 2016–2026
Figure 15: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016–2026
Figure 16: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Academic Research Institutes, 2016–2026
Figure 17: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Other End-users, 2016–2026
Figure 18: Global Viral Clearance Service Market Attractiveness Analysis, by End-user, 2018–2026
Figure 19: Global Viral Clearance Service Market Value Share, by Region, 2017 and 2026
Figure 20: Global Viral Clearance Service Market Attractiveness Analysis, by Region, 2018–2026
Figure 21: North America Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 22: North America Viral Clearance Service Market Value Share, by Country, 2017 and 2026
Figure 23: North America Viral Clearance Service Market Attractiveness, by Country, 2018–2026
Figure 24: North America Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 25: North America Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 26: North America Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 27: North America Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 28: North America Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 29: North America Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 30: Europe Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 31: Europe Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 32: Europe Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 33: Europe Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 34: Europe Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 35: Europe Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 36: Europe Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 37: Europe Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 38: Europe Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 39: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 40: Asia Pacific Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 41: Asia Pacific Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 42: Asia Pacific Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 43: Asia Pacific Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 44: Asia Pacific Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 45: Asia Pacific Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 46: Asia Pacific Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 47: Asia Pacific Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 48: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 49: Latin America Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 50: Latin America Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 51: Latin America Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 52: Latin America Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 53: Latin America Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 54: Latin America Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 55: Latin America Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 56: Latin America Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 57: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 58: Middle East & Africa Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 59: Middle East & Africa Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 60: Middle East & Africa Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 61: Middle East & Africa Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 62: Middle East & Africa Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 63: Middle East & Africa Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 64: Middle East & Africa Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 65: Middle East & Africa Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 66: Competitive Business Strategies
Figure 67: Texcell SWOT
Figure 68: Eurofins Scientific SE SWOT
Figure 69: Charles River Laboratories International, Inc. SWOT
Figure 70: Merck KGaA (BioReliance) SWOT
Figure 66: WuXi AppTec SWOT
Figure 72: Clean Cells SWOT
Figure 73: Vironova Biosafety SWOT

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Viral Clearance Service Market